Literature DB >> 16364866

Contribution of mesenchymal progenitor cells to tissue repair in rat cardiac allografts undergoing chronic rejection.

Gordon D Wu1, Michael E Bowdish, Yang-Sun Jin, Hui Zhu, Noboru Mitsuhashi, Lora W Barsky, Mark L Barr.   

Abstract

BACKGROUND: Mesenchymal progenitor cells (MPC) have recently been demonstrated to actively migrate into cardiac allografts during chronic rejection. This study examines the role of MPC in tissue repair of heart allografts in a rat model of chronic rejection.
METHODS: The potential of a rat MPC line (Ap8c3) to differentiate to myofibroblasts and cardiomyocytes was studied in differentiation cultures. Ap8c3 cells tagged with an enhanced green fluorescent protein (eGFP) reporter gene were engrafted into Fischer 344 (F344) recipients of Lewis (LEW) cardiac allografts. Development of intragraft MPC into scar-forming fibroblasts and cardiomyocytes was studied using immunohistochemistry.
RESULTS: Ap8c3 cells contain fibroblast progenitors (FP) positive for P07 antibody. Transforming growth factor (TGF)-beta stimulation promoted FP to terminally differentiate into myofibroblasts, which express alpha-smooth muscle actin (alphaSMA). In cardiac differentiation culture, Ap8c3 cells were induced by 5-azatiditin (5-aza) to form tropomyosin+ myotubes, and to express mRNA encoding for cardiac troponin I (TnI) and alpha-myosin heavy chain (alphaMHC). Transfusion of eGFP+ Ap8c3 cells to F344 recipients resulted in migration of eGFP(+) cells into LEW heart allografts, as well as homing of the eGFP+ MPC to bone marrow. The majority of eGFP+ cells in the heart allografts appeared to be vimentin-expressing fibroblasts. Foci of eGFP+ myocardium were also detected in all heart allografts, with eGFP+ cardiomyocytes representing 4.8 +/- 1.2% of the allografted eGFP+ cells.
CONCLUSIONS: The data suggest that rat MPC participate in tissue repair in heart allografts by giving rise to scar-forming myofibroblasts and cardiomyocytes.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16364866     DOI: 10.1016/j.healun.2005.05.017

Source DB:  PubMed          Journal:  J Heart Lung Transplant        ISSN: 1053-2498            Impact factor:   10.247


  9 in total

1.  Defective myofibroblast formation from mesenchymal stem cells in the aging murine heart rescue by activation of the AMPK pathway.

Authors:  Katarzyna A Cieslik; Joann Trial; Mark L Entman
Journal:  Am J Pathol       Date:  2011-08-03       Impact factor: 4.307

2.  Mesenchymal stem cells: Molecular characteristics and clinical applications.

Authors:  Farbod Rastegar; Deana Shenaq; Jiayi Huang; Wenli Zhang; Bing-Qiang Zhang; Bai-Cheng He; Liang Chen; Guo-Wei Zuo; Qing Luo; Qiong Shi; Eric R Wagner; Enyi Huang; Yanhong Gao; Jian-Li Gao; Stephanie H Kim; Jian-Zhong Zhou; Yang Bi; Yuxi Su; Gaohui Zhu; Jinyong Luo; Xiaoji Luo; Jiaqiang Qin; Russell R Reid; Hue H Luu; Rex C Haydon; Zhong-Liang Deng; Tong-Chuan He
Journal:  World J Stem Cells       Date:  2010-08-26       Impact factor: 5.326

3.  Prostaglandin E2 as an inhibitory modulator of fibrogenesis in human lung allografts.

Authors:  Natalie M Walker; Linda N Badri; Anish Wadhwa; Scott Wettlaufer; Marc Peters-Golden; Vibha N Lama
Journal:  Am J Respir Crit Care Med       Date:  2012-01-01       Impact factor: 21.405

4.  Resident tissue-specific mesenchymal progenitor cells contribute to fibrogenesis in human lung allografts.

Authors:  Natalie Walker; Linda Badri; Scott Wettlaufer; Andrew Flint; Uma Sajjan; Paul H Krebsbach; Venkateshwar G Keshamouni; Marc Peters-Golden; Vibha N Lama
Journal:  Am J Pathol       Date:  2011-06       Impact factor: 4.307

5.  Mesenchymal stromal cells in bronchoalveolar lavage as predictors of bronchiolitis obliterans syndrome.

Authors:  Linda Badri; Susan Murray; Lyrica X Liu; Natalie M Walker; Andrew Flint; Anish Wadhwa; Kevin M Chan; Galen B Toews; David J Pinsky; Fernando J Martinez; Vibha N Lama
Journal:  Am J Respir Crit Care Med       Date:  2010-12-17       Impact factor: 21.405

6.  The protective effects of bone mesenchymal stem cells on paraquat-induced acute lung injury via the muc5b and ERK/MAPK signaling pathways.

Authors:  Lichun Zhang; Qiuhe Li; Zhenning Liu; Yu Wang; Min Zhao
Journal:  Am J Transl Res       Date:  2019-06-15       Impact factor: 4.060

Review 7.  TGF-beta, IL-6, IL-17 and CTGF direct multiple pathologies of chronic cardiac allograft rejection.

Authors:  Adam J Booth; D Keith Bishop
Journal:  Immunotherapy       Date:  2010-07       Impact factor: 4.196

8.  Ang II-AT2R increases mesenchymal stem cell migration by signaling through the FAK and RhoA/Cdc42 pathways in vitro.

Authors:  Xiu-Ping Xu; Hong-Li He; Shu-Ling Hu; Ji-Bin Han; Li-Li Huang; Jing-Yuan Xu; Jian-Feng Xie; Ai-Ran Liu; Yi Yang; Hai-Bo Qiu
Journal:  Stem Cell Res Ther       Date:  2017-07-12       Impact factor: 6.832

9.  Donor-But Not Recipient-Derived Cells Produce Collagen-1 in Chronically Rejected Cardiac Allografts.

Authors:  Saidou Balam; Simone Buchtler; Frederike Winter; Kathrin Schmidbauer; Sophia Neumayer; Yvonne Talke; Kerstin Renner; Edward K Geissler; Matthias Mack
Journal:  Front Immunol       Date:  2022-01-19       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.